Is Ambrx Biopharma Inc. (AMAM) a Buy, Sell, or Hold?
NYSE : AMAM
Ambrx Biopharma Inc. — Institutional Ownership
$28 USD
$0.02 (0.07%)
- Volume
- 1.42M
- Average Volume
- 2M
- Market Capitalization
- $1.77B
- P/E Ratio
- -13.86
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $28.15
- Year Low
- $6.55
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $5.44
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2023-10-10 | HOPU Reunion Company Ltd. | 38.95M | 8.90% |
| 2023-09-25 | Paradigm BioCapital Advisors LP | 25.17M | 5.70% |
| 2023-03-16 | D. E. Shaw & Co., L.L.C. | 22.05M | 8.20% |
| 2023-03-16 | D. E. Shaw Valence Portfolios, L.L.C. | 16.54M | 6.10% |
| 2023-03-16 | David E. Shaw | 22.05M | 8.20% |
| 2023-03-16 | D. E. Shaw & Co., L.P. | 22.05M | 8.20% |
| 2023-03-03 | Capital LP | 26.25M | 9.70% |
| 2023-03-03 | Capital Master LP | 26.25M | 9.70% |
| 2023-02-27 | Venrock Healthcare Capital Partners EG, L.P. | 26.74M | 9.90% |
| 2023-02-27 | Shah, Nimish | 26.74M | 9.90% |
| 2023-02-27 | Koh, Bong | 26.74M | 9.90% |
| 2023-02-27 | VHCP Management III, LLC | 26.74M | 9.90% |
| 2023-02-27 | VHCP Management EG, LLC | 26.74M | 9.90% |
| 2023-02-27 | Venrock Healthcare Capital Partners III, L.P. | 26.74M | 9.90% |
| 2023-02-27 | VHCP Co-Investment Holdings III, LLC | 26.74M | 9.90% |
| 2022-12-19 | Darwin Global Master Fund, Ltd. | 46.93M | 17.40% |
| 2022-12-19 | Dr. Abhishek Trehan | 50.64M | 18.70% |
| 2022-12-19 | Darwin Global Management, Ltd. | 50.64M | 18.70% |
| 2022-03-10 | Abigail P. Johnson | 26.81M | 10.68% |
| 2022-03-10 | FMR LLC | 26.81M | 10.68% |
| 2022-02-14 | Bihua Chen | 17.27M | 7.06% |
| 2022-02-14 | Cormorant Global Healthcare Master Fund, LP | 7.51M | 3.07% |
| 2022-02-14 | Cormorant Private Healthcare Fund III, LP | 9.73M | 3.98% |
| 2022-02-14 | Cormorant Private Healthcare GP III, LLC | 9.73M | 3.98% |
| 2022-02-14 | Cormorant Asset Management, LP | 17.27M | 7.06% |
| 2022-02-14 | Cormorant Global Healthcare GP, LLC | 7.51M | 3.07% |
| 2022-02-11 | HBM Healthcare Investments (Cayman) Ltd. | 16.86M | 6.90% |
| 2022-02-08 | WuXi PharmaTech Healthcare Fund I L.P. | 21.27M | 8.70% |
| 2022-02-08 | WuXi AppTec (Hong Kong) Holding Limited | 8M | 3.30% |
| 2022-02-08 | WuXi AppTec Co., Ltd. | 29.27M | 12.00% |
| 2022-01-18 | Adage Capital Partners, L.P. | 14.19M | 5.80% |
| 2022-01-18 | Phillip Gross | 14.19M | 5.80% |
| 2022-01-18 | Robert Atchinson | 14.19M | 5.80% |
| 2022-01-18 | Adage Capital Partners GP, L.L.C. | 14.19M | 5.80% |
| 2022-01-18 | Adage Capital Advisors, L.L.C. | 14.19M | 5.80% |
| 2021-07-12 | Mr. Amaury Wittouck | 15.07M | 5.70% |
| 2021-07-12 | Invus Public Equities Advisors, LLC | 15.07M | 5.70% |
| 2021-07-12 | Artal Treasury Limited | 15.07M | 5.70% |
| 2021-07-12 | Artal International S.C.A. | 15.07M | 5.70% |
| 2021-07-12 | Artal Group S.A. | 15.07M | 5.70% |
| 2021-07-12 | Westend S.A. | 15.07M | 5.70% |
| 2021-07-12 | Stichting Administratiekantoor Westend | 15.07M | 5.70% |
| 2021-07-12 | Artal International Management S.A. | 15.07M | 5.70% |
| 2021-07-12 | Invus Public Equities, L.P. | 15.07M | 5.70% |
| 2021-07-02 | Cormorant Asset Management, LP | 17.4M | 6.60% |
| 2021-07-02 | Cormorant Global Healthcare Master Fund, LP | 7.51M | 2.85% |
| 2021-07-02 | Cormorant Private Healthcare GP III, LLC | 9.73M | 3.69% |
| 2021-07-02 | Cormorant Private Healthcare Fund III, LP | 9.73M | 3.69% |
| 2021-07-02 | Cormorant Global Healthcare GP, LLC | 7.51M | 2.85% |
| 2021-07-02 | HBM Healthcare Investments (Cayman) Ltd. | 17.75M | 6.70% |
| 2021-07-02 | Bihua Chen | 17.4M | 6.60% |
AMAM Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2022-12-31 | $2.27 | 38.61M | $87.64M | $55.61M | $11.98M | $44M |
| 2021-12-31 | $9.03 | 20.45M | $184.7M | $170.06M | $13.13M | $27.76M |
| 2020-12-31 | $17.05 | 37.67M | $642.26M | $90.46M | $3.19M | $555M |
| 2019-12-31 | $17.05 | 37.67M | $642.26M | $15.49M | $4.65M | $631.42M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2023-09-30 | $11.50 | 62.25M | $715.88M | $225.26M | $10.52M | $501.14M |
| 2023-06-30 | $16.46 | 55.9M | $920.07M | $228.26M | $11.02M | $702.83M |
| 2023-03-31 | $8.92 | 45M | $401.36M | $149.58M | $11.5M | $263.28M |
| 2022-12-31 | $2.27 | 38.62M | $87.67M | $55.61M | $11.98M | $44.04M |
| 2022-09-30 | $1.08 | 38.62M | $41.71M | $55.61M | -$ | -$13.9M |
| 2022-06-30 | $2.65 | 38.6M | $102.3M | $65.64M | $12.57M | $49.23M |
| 2022-03-31 | $4.12 | 38.59M | $158.99M | -$ | -$ | $158.99M |
| 2021-12-31 | $9.03 | 20.45M | $184.7M | $170.06M | $13.13M | $27.76M |
| 2021-09-30 | $13.50 | 38.37M | $518.02M | -$ | -$ | $518.02M |
| 2021-06-30 | $19.60 | 2.54M | $49.7M | $167.2M | $2.41M | -$115.09M |
| 2021-03-31 | $17.05 | 2.54M | $43.23M | -$ | -$ | $43.23M |
| 2020-12-31 | $17.05 | 13.61M | $232.01M | $90.46M | $3.19M | $144.74M |